Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: Reference to effect on quiescent tumour cells

International Journal of Hyperthermia

Volumn 15, Issue 1, 1999, Pages 7-16

  Masunaga, S ^a   Ono, K ^a   Hori, H ^b   Kinashi, Y ^a   Suzuki, M ^a   Takagaki, M ^a   Kasai, S ^b   Nagasawa, H ^b   Uto, Y ^b  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Micronucleus; Mild hyperthermia; Nicotinamide; Quiescent cell; Tirapazamine

Indexed keywords

BROXURIDINE; CYTOCHALASIN B; NICOTINAMIDE; TIRAPAZAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HYPERTHERMIC THERAPY; IMMUNOFLUORESCENCE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MICRONUCLEUS; MOUSE; NONHUMAN; TIME; TUMOR;

ANIMALS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HYPERTHERMIA, INDUCED; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICRONUCLEI, CHROMOSOME-DEFECTIVE; NEOPLASM TRANSPLANTATION; NIACINAMIDE; TRIAZINES;

EID: 0033038947     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/026567399285819     Document Type: Article

References (28)

1. BROWN, J. M., 1993, SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. British Journal of Cancer, 67, 1163-1170.
2. BROWN, J. M., and SIIM, B. G., 1996, Hypoxia-specific cytotoxins in cancer therapy. Seminars in Radiation Oncology, 6, 22-36.
3. DETHLEFSEN, L. A., 1980, In quest of the quaint quiescent cells. Radiation Biology in Cancer Research, edited by R. E. Meyn and H. R. Withers (New York: Raven Press). pp. 415-435.
4. DEWEY, W. C., 1994, Arrhenius relationship from the molecule and cell to clinic. International Journal of Hyperthermia, 10, 457-483.
5. FENECH, M., and MORLEY, A. A., 1985, Measurement of micronuclei in lymphocytes. Mutation Research, 147, 29-36.
6. HORSMAN, M. R., CHAPLIN, D. J., and BROWN, J. M., 1989, Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation. Radiation Research, 118, 139-150.
7. JACKSON, R. C., 1989, The problem of the quiescent cancer cell. Advances in Enzyme Regulation, 29, 27-46.
8. KENNEDY, K. A., TEICHER, B. A., ROCKWELL, S., and SARTORELLI, A. C., 1979, The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochemistry and Pharmacology, 29, 1-8.
9. KJELLEN, E., JOINER, M. C., COLLIER, J. M., JOHNS, H., and ROJAS, A.A., 1991. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiotherapy and Oncology, 22, 81-91.
10. KOCH, C. J., 1993, Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin. Cancer Research, 53, 3992-3997.
11. MASUNAGA, S., ONO, K., and ABE, M., 1992, Potentially lethal damage repair by quiescent cells in murine solid tumors. International Journal of Radiation Oncology Biology Physics, 22, 973-978.
12. MASUNAGA, S., ONO, K., and ABE, M., 1993, The detection and modification of the hypoxic fraction in queiescent cell populations in murine solid tumours. British Journal of Radiology, 66, 918-926.
13. MASUNAGA, S., ONO, K., AKABOSHI, M., KAWAI, K., SUZUKI, M., KINASHI, Y., and TAKAGAKI, M., 1997a, Augmentation in chemosensitivity of intratumor queiscent cells by combined treatment with nicotinamide and mild hyperthermia. Japanese Journal of Cancer Research, 88, 770-777.
14. MASUNAGA, S., ONO, K., SUZUKI, M., KINASHI, Y., TAKAGAKI, M., and AKABOSHI, M., 1997b, Alteration in the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures. International Journal of Hyperthermia, 13, 401-411.
15. MITCHELL, J., MORSTYN, G., RUSSO, A., KINSELLA, T., FORNANCE, A., MCPHERSON, S. GLATSTEIN, E., 1984, Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR. International Journal of Radiation Oncology Biology Physics, 10, 1447-1451.
16. NISHIMURA, Y., ONO, K., HIRAOKA, M., MASUNAGA, S., JO, S., SHIBAMOTO, Y., SASAI, K., ABE, M., IGA, K., and OGAWA, Y., 1990, Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiation Research, 122, 161-167.
17. NISHIMURA, Y., SHIBAMOTO, Y., JO, S., AKUTA, K., HIRAOKA, M., TAKAHASHI, M., and ABE, M., 1988, Relationship between heat-induced vascular damage and thermo-sensitivity in four mouse tumors. Cancer Research, 48, 7226-7230.
18. OLESON, J. R. 1995, Hyperthermia from the clinic to the laboratory: hypothesis (Eugene Robinson Special Lecture). International Journal of Hyperthermia, 11, 315-322.
19. ONO, K., WANDL, E. O., TSUTSUI, K., SASAI, K., and ABE, M., 1989, The correlation between cell survival curve and dose response curve of micronucleus (MN) frequency. Strahlentherapie und Onkologie, 165, 824-827.
20. OVERGAARD, J., 1989, Sensitization of hypoxic tumor cells - clinical experience. International Journal of Radiation Biology, 56, 801-811.
21. OVERGAARD, J., and HORSMAN, M., 1996, Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Seminars in Radiation Oncology, 6, 10-21.
22. OVERGAARD, J., GONZALES, D. G., HULSHUR, M. C. C. M., ARCHANGELI, G., DAHL, O., MELLA, O., and BENTZEN, S. M., 1995, Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. The Lancet, 345, 540-543.
23. PETERS, C. E., CHAPLIN, D. J., and HIRST, D. G., 1997, Nicotinamide reduces tumour interstitial fluid pressure in a dose-and time-dependent manner. British Journal of Radiology, 70, 160-167.
24. SONG, C. W., SHAKIL, A., OSBORN, J. L., and IWATA, K., 1996, Tumour oxygenation is increased by hyperthermia at mild temperatures. International Journal of Hyperthermia, 12, 367-373.
25. VAUPEL, P., 1990, Pathological mechanisms of hyperthermia in cancer therapy. Biological Basis for Oncologic Thermotherapy, edited by M. Gautherie (Heidelberg: Springer-Verlag), pp. 73-134.
26. WALLEN, C. A., RIDINGER, D. N., and DETHLEFSEN, L. A., 1985, Heterogeneity of X-ray cytotoxicity in proliferating and quiescent murine mammary carcinoma cells. Cancer Research, 45, 3064-3069.
27. WOUTERS, B. G., and BROWN, J. M., 1997, Cells at intermediate oxygen levels can be more important than the 'hypoxic fraction' in determining tumor response to fractionated radiotherapy. Radiation Research, 147, 541-550.
28. ZEMAN, E. M., BROWN, J. M., LEMMON, M. J., HIRST, V. K., and LEE, W. W., 1986, SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. International Journal of Radiation Oncololgy Biology Physics, 12, 1239-1242.